Michaela Dinerman News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Michaela dinerman. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Michaela Dinerman Today - Breaking & Trending Today

Viking Therapeutics (NASDAQ:VKTX) Trading Down 4.4%

Shares of Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) dropped 4.4% on Monday . The company traded as low as $23.17 and last traded at $23.19. Approximately 1,773,898 shares were traded during trading, a decline of 50% from the average daily volume of 3,562,957 shares. The stock had previously closed at $24.27. Wall Street Analysts […] ....

San Diego , United States , Stifel Nicolaus , Knott Davidm Jr , Greg Zante , Roth Mkm , Michaela Dinerman , Therapeutics Inc , Securities Exchange Commission , Cheyne Capital Management United Kingdom , Maxim Group , Viking Therapeutics , Get Rating , Therapeutics Trading Down , Exchange Commission , Global Partners , Capital Management , Brian Lian , Viking Therapeutics Daily ,

100,000 Shares in Viking Therapeutics, Inc. (NASDAQ:VKTX) Bought by Moore Capital Management LP

Moore Capital Management LP bought a new position in Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) during the 4th quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The firm bought 100,000 shares of the biotechnology company’s stock, valued at approximately $940,000. Moore Capital Management LP owned 0.13% […] ....

United States , San Diego , Raymond James , Charlesa Rowland Jr , Michaela Dinerman , Vanguard Group Inc , Therapeutics Inc , Securities Exchange Commission , Dimensional Fund Advisors , Maxim Group , Balyasny Asset Management , Marshall Wace , Exchange Commission , Blackrock Inc , Therapeutics Company Profile , Moore Capital Management , Viking Therapeutics , Get Rating , Capital Management , Asset Management , Fund Advisors , Director Charles , Brian Lian , Visit Holdingschannel , Viking Therapeutics Daily , Nasdaq Vktx ,

Viking Therapeutics (NASDAQ:VKTX) Trading Up 3.7%

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) rose 3.7% during mid-day trading on Wednesday . The company traded as high as $21.49 and last traded at $21.41. Approximately 793,171 shares were traded during mid-day trading, a decline of 78% from the average daily volume of 3,674,765 shares. The stock had previously closed at $20.64. Wall […] ....

San Diego , United States , Michaela Dinerman , Lawson Macartney , Knott Davidm Jr , Raymond James , Roth Mkm , Sg Americas Securities , Cheyne Capital Management United Kingdom , Therapeutics Inc , Herr Investment Group , Securities Exchange Commission , Viking Therapeutics , Get Rating , Truist Financial , Exchange Commission , Director Lawson Macartney , Capital Management United Kingdom , Investment Group , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx ,

Viking Therapeutics, Inc. (NASDAQ:VKTX) Receives Consensus Recommendation of "Moderate Buy" from Brokerages

Viking Therapeutics, Inc. (NASDAQ:VKTX – Get Rating) has been assigned an average recommendation of “Moderate Buy” from the nine research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a sell recommendation and four have issued a buy recommendation on the company. The average twelve-month target price […] ....

San Diego , United States , Stifel Nicolaus , Michaela Dinerman , Zurcher Kantonalbank Zurich Cantonalbank , Roth Mkm , Lawson Macartney , Maxim Group , Great West Life Assurance Co , Therapeutics Company Profile , Therapeutics Inc , Denali Advisors , Securities Exchange Commission , Sassicaia Capital Advisers , Viking Therapeutics , Get Rating , Director Lawson Macartney , Exchange Commission , West Life Assurance , Kantonalbank Zurich Cantonalbank , Bay Capital Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx ,

Viking Therapeutics (NASDAQ:VKTX) Price Target Increased to $37.00 by Analysts at Raymond James

Viking Therapeutics (NASDAQ:VKTX – Get Rating) had its target price hoisted by Raymond James from $35.00 to $37.00 in a report published on Wednesday morning, The Fly reports. Other research analysts also recently issued research reports about the stock. Truist Financial upped their price objective on shares of Viking Therapeutics from $28.00 to $32.00 and […] ....

San Diego , United States , Marianna Mancini , Michaela Dinerman , Greg Zante , Stifel Nicolaus , Roth Mkm , Raymond James , Cetera Advisor Networks , Maxim Group , Envestnet Asset Management Inc , Virtu Financial , Therapeutics Inc , Viking Therapeutics , Get Rating , Moderate Buy , Advisor Networks , Gate Manager , Envestnet Asset Management , Brian Lian , Viking Therapeutics Daily , Nasdaq Vktx , Boost Price Target ,